MedTrace Logo

Effectiveness of Hydroxychloroquine in Covid-19 Patients

NCT04328272 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2020-04-02

No results posted yet for this study

Summary

To find the effectiveness of hydroxychloroquine alone and adjuvant with azithromycin in mild to severe Covide-19 pneumonia patients admitted to Coronavirus cell/ward of Ayub Teaching hospital, Abbottabad Pakistan. A single centered, single-blind randomized control trial study.

Conditions

  • COVID19

Interventions

DRUG

Hydroxychloroquine 200 Mg Oral Tablet

Hydroxychloroquine administered orally with water

DRUG

Azithromycin 500Mg Oral Tablet

Azithromycin administered orally with water

DIETARY_SUPPLEMENT

Glucose tablets

administered orally with water

Sponsors & Collaborators

  • Ayub Medical College, Abbottabad

    collaborator OTHER

  • Prof. Dr. Umar Farooq

    lead OTHER

Principal Investigators

  • Umar Farooq, PhD · Khyber Medical University Peshawer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-28
Primary Completion
2020-05-28
Completion
2020-06-28

Countries

  • Pakistan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04328272 on ClinicalTrials.gov